Synthesis and pharmacology of (R)- and (S)-4'-hydroxy-Δ9-tetrahydrocannabinols

European Journal of Medicinal Chemistry

Volumn 32, Issue 2, 1997, Pages 165-170

  Singer, M ^a   Dutta, A K ^a   Compton, D R ^b   Martin, B R ^b   Razdan, R K ^a  

^a ORGANIX INC   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(R) and (S) 4' hydroxy 9 tetrahydrocannabinol; Cannabinoid; Catalepsy; Hypothermia

Indexed keywords

4' HYDROXY DELTA9 TETRAHYDROCANNABINOL; CANNABINOID; CANNABINOID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN CORTEX; CATALEPSY; CHIRALITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HYPOTHERMIA; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0031059864     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)87544-7     Document Type: Article

References (17)

1. 1 Widman M, Nordquist M, Dollery CT, Briant RH (1973) J Pharm Pharmacol 27, 842-848
2. 2 Agurell S, Binder M, Fonseka K et al (1976) In: Marihuana, Chemistry, Biochemistry, and Cellular Effects (Nahas G, ed), Springer, New York, 141-155
3. 3 Harvey DJ, Martin BR, Paton WDM (1978) In: Recent Development in Mass Spectrometry in Biochemistry and Medicine (Frigerio A, ed), Plenum, New York, 161-184
4. 4 Ohlsson A, Agurell S, Leander K et al (1979) Acta Pharm Suec 16, 21-33
5. 5 Widman M, Halldin M, Martin BR (1979) In: Marihuana Biological Effects (Nahas GG, Paton WDM, eds). Pergamon, Oxford, UK, 101-103
6. 6 Ohlsson A, Widman M, Carlsson S, Ryman T, Strid C (1980) Acta Pharmacol Toxicol 47, 308-317
7. 7 Halldin MM, Widman MV, Bahr CV, Lindgren JE, Martin BR (1982) Drug Metab Dispos 10, 297-301
8. 8 Agurell S, Halldin M, Lindgren JE et al (1986) Pharmacol Rev 38, 21-43
9. 9 Sard H, Duffley RP, Robertson LR, Razdan RK (1984) Synthesis 506-509
10. 10 Martin BR, Kallman MJ, Kaempf GF, Harris LS, Dewey WL, Razdan RK (1984) Pharmacol Biochem Behav 21, 61-65
11. 11 Thomas BF, Compton DR, Martin BR, Semus SF (1991) Mol Pharmacol 40, 656-665
12. 12 Martin BR, Compton DR, Thomas BF et al (1991) Pharmacol Biochem Behav 40, 471-478
13. 13 Singer M, Siegel C, Gordon PM, Dutta AK, Razdan RK (1994) Synthesis, 486-188
14. 14 Dale JA, Dull DL, Mosher HS (1969) J Org Chem 34, 2543-2549
15. 15 Keinan E, Sinha SC, Sinha-Bagehi A (1992) J Org Chem 57, 3631-3636
16. 16 Ryan W, Singer M, Razdan RK, Compton DR, Martin BR (1995) Life Sci 56, 2013-2020
17. 17 Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR (1994) J Pharmac Exp Ther 270, 219-227